Status:
COMPLETED
Cold Milk for Dysphagia in Preterm Infants
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Dysphagia of Newborn
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
It is estimated that 30-70% of very low birth weight (VLBW) preterm infants will be diagnosed with swallowing dysfunction (dysphagia), which often leads to airway compromise in the form of laryngeal p...
Eligibility Criteria
Inclusion
- Viable preterm infants less than 34 weeks gestation
- admitted to NYU- Langone Long Island Hospital NICU
- PMA \> 35 weeks at the time of the study
- receiving no or minimum respiratory support (\<2 lit/min low-flow nasal cannula)
- tolerating at least 50% of their enteral feeding orally and
- having symptoms of swallowing dysfunction during oral feeding (clinical dysphagia).
- referred by the medical team for VFSS and/or FEES assessments.
Exclusion
- Infants with other comorbidities, such as IUGR, upper airway anomalies, brain injury, neuromuscular disease, or life-threatening congenital disease.
Key Trial Info
Start Date :
January 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 12 2024
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04421482
Start Date
January 4 2021
End Date
March 12 2024
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016